Post-transplant lymphoproliferative disorder, early lesion

Description

A lymphoproliferative disorder arising as a result of post-transplant immunosuppression therapy. It is characterised by the lack of tissue destruction and the architectural preservation of the involved tissues. It includes two morphologic variants: plasmacytic hyperplasia and infectious mononucleosis-like lymphoproliferative disorders.

Index terms

Post-transplant lymphoproliferative disorder, early lesion

Exclusions from above levels

2E03 – Malignant neoplasm metastasis in bone or bone marrow
http://id.who.int/icd/entity/501778925 – Malignant neoplasm metastasis in lymph nodes
http://id.who.int/icd/entity/97145147 – Malignant neoplasm metastasis in thymus gland

Sibling codes

2B32.1 – Reactive plasmacytic hyperplasia
2B32.2 – Post-transplant lymphoproliferative disorder, Infectious mononucleosis-like
2B32.3 – Polymorphic post-transplant lymphoproliferative disorder
2B32.Y – Other specified immunodeficiency-associated lymphoproliferative disorders
2B32.Z – Immunodeficiency-associated lymphoproliferative disorders, unspecified

Foundation entity

Post-transplant lymphoproliferative disorder, early lesion – http://id.who.int/icd/entity/713946165

Allowed postcoordination axes

Part of: 2B32: Immunodeficiency-associated lymphoproliferative disorders › 02: Neoplasms